G
Last Price
52 Week Range
CA$0.28 - CA$1.25
Next Earnings Date
Dec 29 2025 (Estimate)
Next Earnings Date
Dec 29 2025 (Est.)
Last Price
Market Cap | CA$28.33M |
EV | CA$28.56M |
Shares Outstanding | 76.92M |
Beta | 0.22 |
Industry | Biotechnology |
Analyst Rating | - |
Analyst Target Price | - |
Number of Analysts | 0 |
P/E E | - |
P/Revenue E | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin E | - |
Net Profit Margin E | - |
ROE E | - |
ROCE | - |
DPS E | - |
Payout Ratio E | - |
Div. Yield E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
G
Gemina Laboratories Ltd.
GLAB
Sector
Healthcare
Industry
Biotechnology
CEO
Firth, Brian
Employees
6
Website
www.geminalabs.comIPO Date
2021-08-12
Headquarters
3600 Gilmore Way, Unit 302, Burnaby, British Columbia, V5G 4W8, Canada
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.